| Business Summary | | Ventiv
Health,
Inc.
provides
global
marketing
and
sales
services
for
the
pharmaceutical
and
life
sciences
industries.
The
Company
offers
its
full
spectrum
of
marketing
and
sales
services
through
its
three
operating
groups:
Health
Products
Research,
the
Healthcare
Communications
Group
and
the
Contract
Sales
Group. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Ventiv
Health,
Inc.
provides
global
marketing
and
sales
services
for
pharmaceutical,
biotechnology,
medical
device,
and
diagnostics
companies.
For
the
six
months
ended
6/30/01,
revenues
rose
5%
to
$208
million.
Net
income
fell
48%
to
$3.6
million.
Revenues
reflect
new
contracts
and
expansions
of
relationships
with
Bayor,
Endo,
and
Reliant
Pharmaceuticals.
Net
income
reflects
the
absences
of
recapitalization
and
a
loss
on
the
investment
in
equity
of
non-affiliate. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Daniel Snyder, 36 Co-Chairperson
of the Board of Directors | -- | Michele Snyder, 38 Co-Chairperson
of the Board of Directors | -- | Eran Broshy, 42 CEO | $425K | John Emery, 44 CFO | -- | Joseph Durko, 34 VP,
Controller | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|